iNtRON Biotechnology Inc (048530) — Cash Flow Reinvestment Rate
iNtRON Biotechnology Inc (048530) has a Cash Flow Reinvestment Rate of 0.88x as of March 2025, reinvesting ₩1.70 Billion (capex ₩321.62 Million plus investments ₩1.38 Billion) from operating cash flow of ₩1.94 Billion. Check iNtRON Biotechnology Inc (048530) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
iNtRON Biotechnology Inc Cash Flow Reinvestment Rate (2015–2023)
Historical reinvestment intensity for iNtRON Biotechnology Inc across 6 annual periods. Explore iNtRON Biotechnology Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for iNtRON Biotechnology Inc (2015–2023)
Year-by-year capital reinvestment analysis for iNtRON Biotechnology Inc. For live market cap and broader valuation context, see market value of iNtRON Biotechnology Inc.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 19.79x | ₩61.70 Billion | ₩3.12 Billion | ₩9.55 Billion | ▲ +157.7% |
| 2022 | 7.68x | ₩45.90 Billion | ₩5.98 Billion | ₩2.23 Billion | ▲ +207.6% |
| 2021 | 2.50x | ₩41.13 Billion | ₩16.47 Billion | ₩3.05 Billion | ▲ +38.5% |
| 2020 | 1.80x | ₩12.86 Billion | ₩7.13 Billion | ₩4.85 Billion | ▲ +634.2% |
| 2018 | 0.25x | ₩1.03 Billion | ₩4.20 Billion | ₩550.58 Million | ▼ -95.3% |
| 2015 | 5.19x | ₩8.83 Billion | ₩1.70 Billion | ₩6.30 Billion | — |